Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dewar

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
Calcified Tissue International|September 18, 2007
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone diseaseJ E Brown, E V McCloskey, J A Dewar, et al.
International Journal of Cardiology|June 15, 2004
Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemiaM J Leckie, A H Gomma, I F Purcell, et al.
Breast (Edinburgh, Scotland)|March 20, 2012
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyA Fong, J Shafiq, C Saunders, et al.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Marine Pollution Bulletin|January 24, 2025
A new approach for assessing the radioecological risk associated with the legacy discharge of oil derived natural radioactivity in the UK North SeaF Dal Molin, D Hunt, A Dewar, et al.
Pain Research & Management|December 17, 2009
A survey of prelicensure pain curricula in health science faculties in Canadian universitiesJ Watt-Watson, M McGillion, J Hunter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa studyM Martin, P Fumoleau, J A Dewar, et al.
Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.
British Journal of Cancer|January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancerL Baker, P R Quinlan, N Patten, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 1, 2005
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injuryK Ulrich, M Stern, M E Goddard, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Calcified Tissue International|September 18, 2007
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone diseaseJ E Brown, E V McCloskey, J A Dewar, et al.
International Journal of Cardiology|June 15, 2004
Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemiaM J Leckie, A H Gomma, I F Purcell, et al.
Breast (Edinburgh, Scotland)|March 20, 2012
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyA Fong, J Shafiq, C Saunders, et al.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Marine Pollution Bulletin|January 24, 2025
A new approach for assessing the radioecological risk associated with the legacy discharge of oil derived natural radioactivity in the UK North SeaF Dal Molin, D Hunt, A Dewar, et al.
Pain Research & Management|December 17, 2009
A survey of prelicensure pain curricula in health science faculties in Canadian universitiesJ Watt-Watson, M McGillion, J Hunter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa studyM Martin, P Fumoleau, J A Dewar, et al.
Anti-Cancer Drugs|August 1, 1996
Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivityI A Cree, C M Kurbacher, M Untch, et al.
British Journal of Cancer|January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancerL Baker, P R Quinlan, N Patten, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 1, 2005
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injuryK Ulrich, M Stern, M E Goddard, et al.
Pageof 29